MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to halt Cancer's deadly spread
Disease control Recruiting nowThis early-phase trial tests a new drug called metarrestin in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors or stop them from growing further. The study includes adults with certain cancers and children aged 12…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Blood test could spot rare cancer early in NF1 patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test (liquid biopsy) can detect a rare but serious cancer called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will collect blood samples and surveys from 1,000 participants every six months for…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Sponsor: David Miller • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC